REGN - REGENERON PHARMACEUTICALS, INC.
716.72
-3.290 -0.459%
Share volume: 1,426,923
Last Updated: Wed 05 Feb 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.20%
PREVIOUS CLOSE
CHG
CHG%
$720.01
19.67
0.03%
Summary score
46%
Profitability
64%
Dept financing
24%
Liquidity
70%
Performance
28%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
7.43%
Return on assets
5.53%
Return on sales
39.97%
Return on invested capital
19.77%
Total debt ratio
26.45%
Debt ratio change over timeo
1.17%
Current Ratio
4.48%
Quick Ratio
3.79%
Cash Position Ratio
1.97%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.8%
Return on assets
3.28%
Return on sales
30.73%
Return on invested capital
9.18%
Total debt ratio
21.77%
Debt ratio change over timeo
1.41%
Current Ratio
5.37%
Quick Ratio
4.6%
Cash Position Ratio
2.46%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
2.67%
Return on assets
2.25%
Return on sales
24.6%
Return on invested capital
6.06%
Total debt ratio
21.47%
Debt ratio change over time
0.88%
Current Ratio
5.27%
Quick Ratio
4.51%
Cash Position Ratio
2.94%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-48.2%
Return on assets
-62.18%
Return on sales
213.22%
Return on invested capital
28.34%
Total debt ratio
117.45%
Debt ratio change over time
1.17%
Current Ratio
39.31%
Quick Ratio
33.15%
Cash Position Ratio
17.51%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | REGN | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 7.43% | 13.03% | 18.15% | 6.63% |
| Return on assets | 5.53% | 2.33% | 3.24% | 5.84% |
| Return on sales | 39.97% | 28.06% | 32.46% | 43.41% |
| Return on invested capital | 19.77% | 2.07% | 5.53% | 34.89% |
| Profitability | 71% | 46% | 62% | 84% |
| Total debt ratio | 26.45% | 90.46% | 90.54% | 24.67% |
| Debt ratio change over time | 1.17% | 435.59% | 17.23% | -0.06% |
| Dept financing | 7% | 50% | 26% | 7% |
| Current Ratio | 5.37% | 0.9% | 1.54% | 3.64% |
| Quick Ratio | 4.6% | 0.8% | 1.06% | 3.42% |
| Cash Position Ratio | 2.46% | 0.39% | 0.54% | 2.77% |
| Liquididy | 64% | 12% | 27% | 73% |
| Short-term ratios | REGN | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 3.8% | 0% | 0% | 5.91% |
| Return on assets | 3.28% | 1.33% | 1.27% | 4.97% |
| Return on sales | 30.73% | 22.54% | 14.41% | 42.59% |
| Return on invested capital | 9.18% | 0% | 0% | 23.7% |
| Profitability | 60% | 20% | 15% | 100% |
| Total debt ratio | 21.77% | 93.47% | 94.09% | 24.56% |
| Debt ratio change over time | 1.41% | 0% | 0% | -0.62% |
| Dept financing | 31% | 25% | 25% | 7% |
| Current Ratio | 5.37% | 0.9% | 1.54% | 3.64% |
| Quick Ratio | 4.6% | 0.8% | 1.06% | 3.42% |
| Cash Position Ratio | 2.46% | 0.39% | 0.54% | 2.77% |
| Liquididy | 72% | 12% | 18% | 61% |